USE OF MEDICAL INFORMATION SYSTEM FOR ASSESSMENT OF THE COST OF THERAPY OF DIABETIC FOOT PATIENTS IN RUSSIA

Author(s)

Matveev N1, Galstyan G2, Sergeeva S2, Dolotova D31Nycomed Russia-CIS, Moscow, Russia, 2Scientific Center for Endocrinology, Moscow, Russia, 3Russian State Medical University, Moscow, Russia

OBJECTIVES: Diabetic foot (DF) is one of the most important complications of diabetes mellitus. If not treated properly, diabetic foot may often lead to infections, amputations, and finally to disability. Unfortunately, only few studies of the cost of diabetic foot treatment were available in Russia, most of the studies were completed about 10 years ago. We suggested that the data of earlier studies could not reflect present level of expenditures. Therefore we launched a study of the cost of diabetic foot treatment in present conditions. METHODS: . We have analyzed the data of 146 in-patients treated in diabetic foot department at Scientific Centre for Endocrinology (Moscow, Russia) in 2008-2009. The patients’ data were input into a specially designed medical information system. The patients were sorted into three main groups: 1) diabetic polyneuropathy without diabetic foot (N=37); 2) diabetic foot without amputations (N=58); and 3) patients with amputations due to diabetic foot (N=51). To calculate the total cost of DF treatment, costs of diagnostic procedures, medicines, bandaging, surgical operations, and staying in the hospital were summed.  RESULTS: . Mean cost of treatment of one DF patient was equal to 81,700 rubles (US$2,645), which is about 30% higher than previously reported figures. It is mainly due to larger introduction of recombinant insulins into routine treatment of diabetic patients.  Mean cost of treatment of DF patients with amputations was significantly higher than in those without amputations, mostly due to additional costs of surgical treatment and longer stay in a hospital. Moreover, the mean cost of medicines for DF patients with amputations was almost twice higher than for DF patients without amputations. CONCLUSIONS: . The cost of diabetic foot treatment in Russia increased approximately 30% during last 10 years.  The results will be used to assess cost-effectiveness of various drug treatments of diabetic foot.

Conference/Value in Health Info

2010-11, ISPOR Europe 2010, Prague, Czech Republic

Value in Health, Vol. 13, No. 7 (November 2010)

Code

PDB30

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×